Interferon therapy in hepatitis C

N. N. Zein, J. Rakela

Research output: Contribution to journalReview article

9 Scopus citations

Abstract

Interferon is effective for the treatment of hepatitis C infection in some patients. Although its effectiveness is established in patients with chronic hepatitis C infection, more work need to be done before it can be recommended for the treatment of patients with acute HCV infection. The currently recommended therapeutic regimen is 3 MU three times weekly, but higher dosages and longer duration of therapy may be more beneficial. Multiple factors including the degree of inflammation and fibrosis, HCV-RNA titer, and HCV genotype may influence the response to therapy. Therefore proper patient selection will improve response rate, and make interferon treatment more cost-effective. No controlled studies have yet evaluated the use of interferon in children with chronic HCV infection. Many questions are yet to be answered regarding interferon therapy in patients with chronic hepatitis C, thus we recommend all patients who belong to these categories be enrolled in clinical trials.

Original languageEnglish (US)
Pages (from-to)46-53
Number of pages8
JournalSeminars in Gastrointestinal Disease
Volume6
Issue number1
StatePublished - Jan 1 1995

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Interferon therapy in hepatitis C'. Together they form a unique fingerprint.

  • Cite this